retatrutide trial Phase 2 of for Obesity retatrutide clinical trial status Retatrutide,

B., & Sood, A

As additional FDA submissions and real-world studies emerge, further clarification of optimal dosing strategies and sustained efficacy will shape its role in future metabolic treatment protocols

Glucagon-like peptide-1 (GLP-1) is a hormone produced in the body that plays a key role in regulating your blood sugar levels

Research has also explored how tri-agonist signaling may affect fat distribution and body composition parameters, including visceral adiposity and total fat mass

The gradual titration schedule starting at low doses and increasing incrementally over several weeks is specifically designed to minimise gastrointestinal effects and improve tolerability

It is currently conducting trials that could ultimately lead to its use in concert with GLP-1 drugs (a process known as adjunctive therapy) so patients dont lose lean muscle